Acneiform eruptions caused by various second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia

Br J Dermatol. 2016 Feb;174(2):456-8. doi: 10.1111/bjd.14185. Epub 2015 Nov 21.

Authors

Y S Jung¹, M Kim¹, J H Lee¹, D W Kim², H J Park¹

Affiliations

¹ Department of Dermatology, College of Medicine, The Catholic University of Korea, 62 Youido-dong, Youngdeunpo-gu, Seoul, Korea.
² Department of Hematology, College of Medicine, The Catholic University of Korea, 62 Youido-dong, Youngdeunpo-gu, Seoul, Korea.

PMID: 26399382
DOI: 10.1111/bjd.14185

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acneiform Eruptions / chemically induced*
Adult
Benzamides / adverse effects
Dasatinib / adverse effects
Facial Dermatoses / drug therapy*
Female
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Male
Protein Kinase Inhibitors / adverse effects*
Protein-Tyrosine Kinases / antagonists & inhibitors*
Pyrazines / adverse effects
Pyrimidines / adverse effects
Young Adult

Substances

4-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide
Benzamides
Protein Kinase Inhibitors
Pyrazines
Pyrimidines
Protein-Tyrosine Kinases
nilotinib
Dasatinib